Increased expression of the active form of Notch1 was detected in 97L and 97H cells but not in other HCC cells in our previous study [22], leading to a hypothesis that sorafenib resistance might be modulated by Notch1. The gene discussed is NOTCH1; the disease is hepatocellular carcinoma.